These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 24188129)

  • 61. Caffeoylquinic Acid Mitigates Neuronal Loss and Cognitive Decline in 5XFAD Mice Without Reducing the Amyloid-β Plaque Burden.
    Suganuma T; Hatori S; Chen CK; Hori S; Kanuka M; Liu CY; Tatsuzawa C; Yanagisawa M; Hayashi Y
    J Alzheimers Dis; 2024; 99(4):1285-1301. PubMed ID: 38788074
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ER stress is not elevated in the 5XFAD mouse model of Alzheimer's disease.
    Sadleir KR; Popovic J; Vassar R
    J Biol Chem; 2018 Nov; 293(48):18434-18443. PubMed ID: 30315100
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interaction of exogenous acetylcholinesterase and butyrylcholinesterase with amyloid-β plaques in human brain tissue.
    Reid GA; Darvesh S
    Chem Biol Interact; 2024 May; 395():111012. PubMed ID: 38648920
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 65. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DNA hypomethylation promotes the expression of CASPASE-4 which exacerbates inflammation and amyloid-β deposition in Alzheimer's disease.
    Daily KP; Badr A; Eltobgy M; Estfanous S; Whitham O; Tan MH; Carafice C; Krause K; McNamara A; Hamilton K; Houle S; Gupta S; Gupta GA; Madhu S; Fitzgerald J; Saadey AA; Laster B; Yan P; Webb A; Zhang X; Pietrzak M; Kokiko-Cochran ON; Ghoneim HE; Amer AO
    Alzheimers Res Ther; 2024 Feb; 16(1):29. PubMed ID: 38326859
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Knockout of apolipoprotein A-I decreases parenchymal and vascular β-amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Contu L; Carare RO; Hawkes CA
    Neuropathol Appl Neurobiol; 2019 Dec; 45(7):698-714. PubMed ID: 31002190
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
    Devi L; Tang J; Ohno M
    Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reduction of the expression of the late-onset Alzheimer's disease (AD) risk-factor
    Andrew RJ; De Rossi P; Nguyen P; Kowalski HR; Recupero AJ; Guerbette T; Krause SV; Rice RC; Laury-Kleintop L; Wagner SL; Thinakaran G
    J Biol Chem; 2019 Mar; 294(12):4477-4487. PubMed ID: 30692199
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.
    Hoshino T; Murao N; Namba T; Takehara M; Adachi H; Katsuno M; Sobue G; Matsushima T; Suzuki T; Mizushima T
    J Neurosci; 2011 Apr; 31(14):5225-34. PubMed ID: 21471357
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tg-SwDI transgenic mice exhibit novel alterations in AbetaPP processing, Abeta degradation, and resilient amyloid angiopathy.
    Van Vickle GD; Esh CL; Daugs ID; Kokjohn TA; Kalback WM; Patton RL; Luehrs DC; Walker DG; Lue LF; Beach TG; Davis J; Van Nostrand WE; Castaño EM; Roher AE
    Am J Pathol; 2008 Aug; 173(2):483-93. PubMed ID: 18599612
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Deletion of the Homocysteine Thiolactone Detoxifying Enzyme Bleomycin Hydrolase, in Mice, Causes Memory and Neurological Deficits and Worsens Alzheimer's Disease-Related Behavioral and Biochemical Traits in the 5xFAD Model of Alzheimer's Disease.
    Witucki Ł; Borowczyk K; Suszyńska-Zajczyk J; Warzych E; Pawlak P; Jakubowski H
    J Alzheimers Dis; 2023; 95(4):1735-1755. PubMed ID: 37718819
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Genetic reductions of beta-site amyloid precursor protein-cleaving enzyme 1 and amyloid-beta ameliorate impairment of conditioned taste aversion memory in 5XFAD Alzheimer's disease model mice.
    Devi L; Ohno M
    Eur J Neurosci; 2010 Jan; 31(1):110-8. PubMed ID: 20092558
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence for Enhanced Efficacy of Passive Immunotherapy against Beta-Amyloid in CD33-Negative 5xFAD Mice.
    Gnoth K; Geissler S; Feldhaus J; Taudte N; Ilse V; Zürner S; Greiser S; Braumann UD; Rahfeld JU; Cynis H; Schilling S
    Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327591
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amyloid β Protein Aggravates Neuronal Senescence and Cognitive Deficits in 5XFAD Mouse Model of Alzheimer's Disease.
    Wei Z; Chen XC; Song Y; Pan XD; Dai XM; Zhang J; Cui XL; Wu XL; Zhu YG
    Chin Med J (Engl); 2016 Aug; 129(15):1835-44. PubMed ID: 27453234
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PKR knockout in the 5xFAD model of Alzheimer's disease reveals beneficial effects on spatial memory and brain lesions.
    Tible M; Mouton Liger F; Schmitt J; Giralt A; Farid K; Thomasseau S; Gourmaud S; Paquet C; Rondi Reig L; Meurs E; Girault JA; Hugon J
    Aging Cell; 2019 Jun; 18(3):e12887. PubMed ID: 30821420
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Low-Dose Ionizing Radiation Modulates Microglia Phenotypes in the Models of Alzheimer's Disease.
    Kim S; Chung H; Ngoc Mai H; Nam Y; Shin SJ; Park YH; Chung MJ; Lee JK; Rhee HY; Jahng GH; Kim Y; Lim YJ; Kong M; Moon M; Chung WK
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630597
    [TBL] [Abstract][Full Text] [Related]  

  • 78. SEN1500, a novel oral amyloid-β aggregation inhibitor, attenuates brain pathology in a mouse model of Alzheimer's disease.
    Brunner D; Flunkert S; Neddens J; Duller S; Scopes DIC; Treherne JM; Hutter-Paier B
    Neurosci Lett; 2017 Nov; 660():96-102. PubMed ID: 28917978
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
    Zhan X; Jickling GC; Ander BP; Stamova B; Liu D; Kao PF; Zelin MA; Jin LW; DeCarli C; Sharp FR
    J Alzheimers Dis; 2015; 44(4):1213-29. PubMed ID: 25697841
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cellular prion protein acts as mediator of amyloid beta uptake by caveolin-1 causing cellular dysfunctions in vitro and in vivo.
    da Silva Correia A; Schmitz M; Fischer AL; da Silva Correia S; Simonetti FL; Saher G; Goya-Maldonado R; Arora AS; Fischer A; Outeiro TF; Zerr I
    Alzheimers Dement; 2024 Oct; 20(10):6776-6792. PubMed ID: 39212313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.